Xenacare Holdings Inc.
3275 W Hillsboro Boulevard
Suite 300
Deerfield Beach,
FL 33442
Phone: 954-363-4507
Web Site: http://www.xenacare.com
| REUTERS ABRIDGED BUSINESS SUMMARY | |
| XenaCare Holdings, Inc. engages in the formulation, marketing, and distribution of nutrition supplement products primarily in the United States. Its clinical products include XenaCor, which lowers serum cholesterol, C-reactive protein, and homocysteine levels, designed to support cardiovascular health; XenaTri for lowering triglycerides and raising HDL to support cardiovascular health; and XenaZyme Plus that increases the bodys oxygen carrying capacities, designed to support digestion. The companys clinical products also comprise body replenishment products. In addition, it offers formulations for the energy/lifestyle performance market, which consists of sports line for athletes, including SunPill that is formulated to protect the skin when exposed to damaging ultraviolet rays. XenaCare markets its products through the Internet, pharmacies, infomercials, and doctors offices. The company was founded in 2001 and is based in Delray Beach, Florida. |
|
| Key Statistics | More from Reuters
Expanded Business Description |
| |
| REUTERS ABRIDGED FINANCIAL SUMMARY | |
| | Pay | Exercised | Dr. Alan Xenakis , 61
Founder and Chairman |
$
144.00K | N/A | Mr. Frank W. Rizzo , 56
Chief Exec. Officer, Pres |
$
144.00K | N/A | Mr. Bobby Story , 69
Chief Financial Officer, Principal Accounting Officer, Sec., Treasurer |
$
144.00K | N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.035 (14.58%)
Reuters offers more in-depth
